Work

Abstract A033: Potential Benefit of Apixaban Among Patients Without High-Risk Hypertension In Cryptogenic Stroke: A Secondary Analysis of the ARCADIA Trial

Year: 2026

Type: conference-abstract

Source: Stroke

DOI: 10.1161/str.57.suppl_1.a033

Authors: Mohamed Ridha, Raed Hailat, Robert Stanton, Alexander Merkler, Mitchell Elkind, W Longstreth, David Tirschwell, Richard Kronmal, Yousef Hannawi, Hooman Kamel, James Burke, Daniel Woo

Institutions: The Ohio State University, University of Cincinnati, Weill Cornell Medicine, Columbia University, Harborview Medical Center, University of Washington, University at Buffalo, State University of New York

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7126051203

Cites:

Cited by:

Related to: